MEDTRONIC PLC (2M6.DE) Fundamental Analysis & Valuation

FRA:2M6IE00BTN1Y115

Current stock price

76.5 EUR
+0.18 (+0.24%)
Last:

This 2M6.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. 2M6.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 2M6 was profitable.
  • In the past year 2M6 had a positive cash flow from operations.
  • Each year in the past 5 years 2M6 has been profitable.
  • Each year in the past 5 years 2M6 had a positive operating cash flow.
2M6.DE Yearly Net Income VS EBIT VS OCF VS FCF2M6.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • The Return On Assets of 2M6 (5.04%) is better than 68.25% of its industry peers.
  • 2M6 has a Return On Equity of 9.42%. This is in the better half of the industry: 2M6 outperforms 65.08% of its industry peers.
  • 2M6 has a Return On Invested Capital of 6.57%. This is comparable to the rest of the industry: 2M6 outperforms 58.73% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 2M6 is below the industry average of 9.72%.
  • The last Return On Invested Capital (6.57%) for 2M6 is above the 3 year average (6.35%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.04%
ROE 9.42%
ROIC 6.57%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
2M6.DE Yearly ROA, ROE, ROIC2M6.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

  • 2M6's Profit Margin of 13.00% is amongst the best of the industry. 2M6 outperforms 80.95% of its industry peers.
  • 2M6's Profit Margin has declined in the last couple of years.
  • 2M6's Operating Margin of 18.98% is fine compared to the rest of the industry. 2M6 outperforms 79.37% of its industry peers.
  • 2M6's Operating Margin has been stable in the last couple of years.
  • With a decent Gross Margin value of 65.16%, 2M6 is doing good in the industry, outperforming 69.84% of the companies in the same industry.
  • 2M6's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.98%
PM (TTM) 13%
GM 65.16%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
2M6.DE Yearly Profit, Operating, Gross Margins2M6.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. 2M6.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 2M6 is still creating some value.
  • Compared to 1 year ago, 2M6 has less shares outstanding
  • 2M6 has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 2M6 is higher compared to a year ago.
2M6.DE Yearly Shares Outstanding2M6.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
2M6.DE Yearly Total Debt VS Total Assets2M6.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 2.91 indicates that 2M6 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • 2M6 has a better Altman-Z score (2.91) than 60.32% of its industry peers.
  • The Debt to FCF ratio of 2M6 is 5.19, which is a neutral value as it means it would take 2M6, 5.19 years of fcf income to pay off all of its debts.
  • 2M6 has a Debt to FCF ratio (5.19) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that 2M6 is somewhat dependend on debt financing.
  • The Debt to Equity ratio of 2M6 (0.57) is worse than 60.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.19
Altman-Z 2.91
ROIC/WACC1
WACC6.54%
2M6.DE Yearly LT Debt VS Equity VS FCF2M6.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 2.54 indicates that 2M6 has no problem at all paying its short term obligations.
  • 2M6 has a Current ratio of 2.54. This is in the better half of the industry: 2M6 outperforms 76.19% of its industry peers.
  • 2M6 has a Quick Ratio of 1.87. This is a normal value and indicates that 2M6 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of 2M6 (1.87) is better than 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 1.87
2M6.DE Yearly Current Assets VS Current Liabilites2M6.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. 2M6.DE Growth Analysis

3.1 Past

  • 2M6 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.87%.
  • 2M6 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.68% yearly.
  • The Revenue has been growing slightly by 6.88% in the past year.
  • Measured over the past years, 2M6 shows a small growth in Revenue. The Revenue has been growing by 3.01% on average per year.
EPS 1Y (TTM)4.87%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%-2.16%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%8.74%

3.2 Future

  • 2M6 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.10% yearly.
  • 2M6 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.02% yearly.
EPS Next Y3.55%
EPS Next 2Y5.66%
EPS Next 3Y6.35%
EPS Next 5Y7.1%
Revenue Next Year7.95%
Revenue Next 2Y7.35%
Revenue Next 3Y6.58%
Revenue Next 5Y6.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
2M6.DE Yearly Revenue VS Estimates2M6.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
2M6.DE Yearly EPS VS Estimates2M6.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

5

4. 2M6.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 15.68, 2M6 is valued correctly.
  • Compared to the rest of the industry, the Price/Earnings ratio of 2M6 indicates a rather cheap valuation: 2M6 is cheaper than 92.06% of the companies listed in the same industry.
  • 2M6's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.71.
  • A Price/Forward Earnings ratio of 14.30 indicates a correct valuation of 2M6.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 2M6 indicates a somewhat cheap valuation: 2M6 is cheaper than 77.78% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of 2M6 to the average of the S&P500 Index (23.83), we can say 2M6 is valued slightly cheaper.
Industry RankSector Rank
PE 15.68
Fwd PE 14.3
2M6.DE Price Earnings VS Forward Price Earnings2M6.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 2M6 is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, 2M6 is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.84
EV/EBITDA 12.75
2M6.DE Per share data2M6.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2M6 does not grow enough to justify the current Price/Earnings ratio.
  • 2M6 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.41
PEG (5Y)4.26
EPS Next 2Y5.66%
EPS Next 3Y6.35%

6

5. 2M6.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.25%, 2M6 has a reasonable but not impressive dividend return.
  • 2M6's Dividend Yield is rather good when compared to the industry average which is at 1.11. 2M6 pays more dividend than 93.65% of the companies in the same industry.
  • 2M6's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 3.25%

5.2 History

  • The dividend of 2M6 has a limited annual growth rate of 5.10%.
Dividend Growth(5Y)5.1%
Div Incr Years7
Div Non Decr Years7
2M6.DE Yearly Dividends per share2M6.DE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 2M6 pays out 78.65% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of 2M6 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP78.65%
EPS Next 2Y5.66%
EPS Next 3Y6.35%
2M6.DE Yearly Income VS Free CF VS Dividend2M6.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
2M6.DE Dividend Payout.2M6.DE Dividend Payout, showing the Payout Ratio.2M6.DE Dividend Payout.PayoutRetained Earnings

2M6.DE Fundamentals: All Metrics, Ratios and Statistics

MEDTRONIC PLC

FRA:2M6 (3/13/2026, 7:00:00 PM)

76.5

+0.18 (+0.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17
Earnings (Next)05-20
Inst Owners87.75%
Inst Owner ChangeN/A
Ins Owners0.28%
Ins Owner ChangeN/A
Market Cap98.22B
Revenue(TTM)35.48B
Net Income(TTM)4.61B
Analysts76.32
Price Target95.91 (25.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.25%
Yearly Dividend2.41
Dividend Growth(5Y)5.1%
DP78.65%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.66%
Min EPS beat(2)0.89%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.6%
Min EPS beat(4)0.89%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.11%
EPS beat(12)9
Avg EPS beat(12)1.9%
EPS beat(16)11
Avg EPS beat(16)1.33%
Revenue beat(2)2
Avg Revenue beat(2)0.17%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.26%
Revenue beat(4)4
Avg Revenue beat(4)0.35%
Min Revenue beat(4)0.08%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.23%
Revenue beat(12)10
Avg Revenue beat(12)0.48%
Revenue beat(16)12
Avg Revenue beat(16)0.07%
PT rev (1m)1%
PT rev (3m)-0.07%
EPS NQ rev (1m)-1.51%
EPS NQ rev (3m)-1.44%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.05%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 15.68
Fwd PE 14.3
P/S 3.18
P/FCF 20.84
P/OCF 15.47
P/B 2.3
P/tB N/A
EV/EBITDA 12.75
EPS(TTM)4.88
EY6.38%
EPS(NY)5.35
Fwd EY6.99%
FCF(TTM)3.67
FCFY4.8%
OCF(TTM)4.94
OCFY6.46%
SpS24.08
BVpS33.25
TBVpS-2.2
PEG (NY)4.41
PEG (5Y)4.26
Graham Number60.42
Profitability
Industry RankSector Rank
ROA 5.04%
ROE 9.42%
ROCE 8.21%
ROIC 6.57%
ROICexc 7.32%
ROICexgc 25.19%
OM 18.98%
PM (TTM) 13%
GM 65.16%
FCFM 15.24%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.19
Debt/EBITDA 2.84
Cap/Depr 60.84%
Cap/Sales 5.28%
Interest Coverage 8.77
Cash Conversion 74.21%
Profit Quality 117.26%
Current Ratio 2.54
Quick Ratio 1.87
Altman-Z 2.91
F-Score7
WACC6.54%
ROIC/WACC1
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)4.87%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%-2.16%
EPS Next Y3.55%
EPS Next 2Y5.66%
EPS Next 3Y6.35%
EPS Next 5Y7.1%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%8.74%
Revenue Next Year7.95%
Revenue Next 2Y7.35%
Revenue Next 3Y6.58%
Revenue Next 5Y6.02%
EBIT growth 1Y4.15%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year18.67%
EBIT Next 3Y11.27%
EBIT Next 5Y9.86%
FCF growth 1Y9.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y12.56%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / 2M6.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MEDTRONIC PLC (2M6.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to 2M6.DE.


What is the valuation status for 2M6 stock?

ChartMill assigns a valuation rating of 5 / 10 to MEDTRONIC PLC (2M6.DE). This can be considered as Fairly Valued.


How profitable is MEDTRONIC PLC (2M6.DE) stock?

MEDTRONIC PLC (2M6.DE) has a profitability rating of 6 / 10.


What is the expected EPS growth for MEDTRONIC PLC (2M6.DE) stock?

The Earnings per Share (EPS) of MEDTRONIC PLC (2M6.DE) is expected to grow by 3.55% in the next year.


Is the dividend of MEDTRONIC PLC sustainable?

The dividend rating of MEDTRONIC PLC (2M6.DE) is 6 / 10 and the dividend payout ratio is 78.65%.